icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
Interim results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of Myrcludex B in combination with PEG-IFNα in patients with chronic HBV/HDV co-infection
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF

1212181

1212182

1212183

1212184

1212185

1212186

1212187